Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes. - Wikidata - wikimedia - TriplyDB

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

http://www.wikidata.org/entity/Q33957589

about

Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.Herman N. Eisen: Mentor to many Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.Elicitation of anti-vesicular stomatitis virus cytotoxic T lymphocytes by using purified viral and cellular antigens incorporated into phospholipid vesicles.Immune mechanisms and the action of interferon in chronic hepatitis B virus infection.

P2860

Q33963535-576E54B9-FD45-414B-9012-A7145290B199 Q34459495-E3F15E57-B4D1-4AB3-9E27-1F014B073E5E Q36411811-43FC1979-1F66-437B-838A-6BDBD81BB1B2 Q36446512-51612A4A-A13E-44F8-B35D-69E45022B48E Q39742025-272E4E1F-5581-42CF-8C8B-6DB615B4E370

P2860

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

http://www.wikidata.org/entity/Q33957589

description

1978 nî lūn-bûn

@nan

1978 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1978 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1978年の論文

@ja

1978年論文

@yue

1978年論文

@zh-hant

1978年論文

@zh-hk

1978年論文

@zh-mo

1978年論文

@zh-tw

1978年论文

@wuu

name

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@ast

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@en

type

label

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@ast

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@en

prefLabel

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@ast

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@en

P1433

Q33957589-DF8E0AFD-A4B1-456F-B739-B8FEDDB8B755

P1476

Q33957589-CB5F508B-ACC7-4A84-AE43-7BD0C3768F2B

P2093

Q33957589-316EDFB7-7A3B-4F98-9A90-B150148B35AD

Q33957589-8E7AB545-F957-45B2-BEDC-F30AFB85E15B

Q33957589-C68DAFD5-AD8E-451D-B53D-181A40CFDFD0

Q33957589-D48493E3-ED8C-42CE-8476-495FD17B9C77

P2860

Q33957589-0B512BA1-BA98-4595-9EC4-115ABDEBE754

Q33957589-5228AD5A-CCF4-4A77-8B9D-1886C2391855

Q33957589-52D0B14B-E2FC-43E2-834B-A0BBAD42B065

Q33957589-55A6F825-1F2A-4EEA-910B-D636D9E582E1

Q33957589-6BD34CFF-6C01-4747-81F2-78C03EA3AEBB

Q33957589-A196F500-5027-4544-A6CE-4D95270284AA

Q33957589-AEA58594-8D9C-4512-8869-76FFC41545EE

Q33957589-AFA0F39A-3992-42EA-A091-CC94A78912AD

Q33957589-B86DBCCC-5615-47E5-9E9E-F6DE10B0BC3C

Q33957589-BAF4C637-BA82-4D80-A2A5-B71E6CC57F85

P304

Q33957589-8C02A921-D530-43D5-89AA-95C2E40818A2

P31

Q33957589-446C71D6-1A02-425B-9368-BC243B2EB485

P356

Q33957589-FE8C64F8-2491-455F-87EA-4C79FCBB22C3

P407

Q33957589-95AC4576-DBEB-4D65-B0A6-06A9D8686D84

P433

Q33957589-9FE9CF67-CAA4-41D9-AA22-B05589446224

P478

Q33957589-D412D416-417F-4293-AE03-EDEE56C08838

P577

Q33957589-EE9E0EEB-FD27-40DE-BF96-E3507524052E

P5875

Q33957589-C16FAC28-3AE3-4AB4-A2E4-754B4871882D

P698

Q33957589-D0F029FD-F845-4752-8837-D689792F2411

P932

Q33957589-91F6CEC2-E5CD-4C0D-AD57-09F2AA7CCD96

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Periodic loss of reactivity of a myeloma tumor with cytotoxic thymus-derived lymphocytes.

@en

P2093

Eisen HN

http://www.w3.org/2001/XMLSchema#string

Ginns LC

http://www.w3.org/2001/XMLSchema#string

Hale AH

http://www.w3.org/2001/XMLSchema#string

Russell JH

http://www.w3.org/2001/XMLSchema#string

P2860

Repetitive maturation cycles in a cultured mouse myeloma.

Immunization of dissociated spleen cell cultures from normal mice.

Surface alloantigens of plasma cells

Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.

H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens

Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the mu

H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras.

Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.

P304

441-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.75.1.441

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1978-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23058229

http://www.w3.org/2001/XMLSchema#string

P698

75547

http://www.w3.org/2001/XMLSchema#string

P932

411265

http://www.w3.org/2001/XMLSchema#string